• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 264-278 of 502 results

2115 Exhibit: FDA Ventavis Label under Action Date 8242005 accessed July 2, 201...

Document IPR2017-01622, No. 2115-316 Exhibit - FDA Ventavis Label under Action Date 8242005 accessed July 2, 2018 (P.T.A.B. Jul. 11, 2018)

cite Cite Document

2052 Exhibit: Letter from FDA confirming IND filing

Document IPR2017-01622, No. 2052-238 Exhibit - Letter from FDA confirming IND filing (P.T.A.B. Apr. 27, 2018)

cite Cite Document

2018 Exhibit: Exhibit 2018

Document IPR2017-01622, No. 2018-180 Exhibit - Exhibit 2018 (P.T.A.B. Oct. 13, 2017)

cite Cite Document

1162 Exhibit: Substantive Submission filed in 12591,200 Nov 9, 2015 with accompa...

Document IPR2017-01622, No. 1162-151 Exhibit - Substantive Submission filed in 12591,200 Nov 9, 2015 with accompanying Declaration of Dr Roham T Zamanian (P.T.A.B. Jun. 21, 2017)

cite Cite Document

1129 Exhibit: Pfizer, Annual Report, 2011

Document IPR2017-01622, No. 1129-119 Exhibit - Pfizer, Annual Report, 2011 (P.T.A.B. Jun. 21, 2017)

cite Cite Document

1002 Exhibit: Declaration of Maureen D Donovan in Support of the Petition for Inter Partes Review of US Patent No 9,339,507

Document IPR2017-01622, No. 1002-162 Exhibit - Declaration of Maureen D Donovan in Support of the Petition for Inter Partes Review of US Patent No 9,339,507 (P.T.A.B. Jun. 21, 2017)

cite Cite Document

2054 Exhibit: Curriculum vitae and Record of Prior Testimony of Dr Jeffrey Stec

Document IPR2017-01622, No. 2054-241 Exhibit - Curriculum vitae and Record of Prior Testimony of Dr Jeffrey Stec (P.T.A.B. Apr. 27, 2018)

cite Cite Document

2014 Exhibit: Exhibit 2014

Document IPR2017-01622, No. 2014-176 Exhibit - Exhibit 2014 (P.T.A.B. Oct. 13, 2017)

cite Cite Document

1150 Exhibit: UTC, Form 10K, 2008

Document IPR2017-01622, No. 1150-139 Exhibit - UTC, Form 10K, 2008 (P.T.A.B. Jun. 21, 2017)

cite Cite Document

1086 Exhibit: Approved Drug Products with Therapeutic Equivalance Evaluations O...

Document IPR2017-01622, No. 1086-78 Exhibit - Approved Drug Products with Therapeutic Equivalance Evaluations Orange Book, FDA 37th ed 2017 (P.T.A.B. Jun. 21, 2017)

cite Cite Document

1035 Exhibit: US Food and Drug Administration, Drug Approval Package Remodulin...

Document IPR2017-01622, No. 1035-30 Exhibit - US Food and Drug Administration, Drug Approval Package Remodulin approved on May 21, 2002, httpwwwaccessdatafdagovdrugsatfda docsnda200221 2...

cite Cite Document

2037 Exhibit: Listing of Issues and Supplements of Circulation Accessible on Circul...

Document IPR2017-01622, No. 2037-223 Exhibit - Listing of Issues and Supplements of Circulation Accessible on Circulation Website accessed April 17, 2018 (P.T.A.B. Apr. 27, 2018)

cite Cite Document

2082 Exhibit: US 9,550,716

Document IPR2017-01622, No. 2082-270 Exhibit - US 9,550,716 (P.T.A.B. Apr. 27, 2018)

cite Cite Document

2104 Exhibit: Bloomberg LP WACC Report for UTHR, 2003

Document IPR2017-01622, No. 2104-300 Exhibit - Bloomberg LP WACC Report for UTHR, 2003 (P.T.A.B. Apr. 27, 2018)

cite Cite Document

2032 Exhibit: Exhibit 2032

Document IPR2017-01622, No. 2032-203 Exhibit - Exhibit 2032 (P.T.A.B. Feb. 28, 2018)

cite Cite Document
<< 1 2 3 4 5 ... 18 19 20 21 22 ... >>